AbbVie (NYSE:ABBV) Stock Rating Upgraded by Barclays
Barclays upgraded shares of AbbVie (NYSE:ABBV – Free Report) from an equal weight rating to an overweight rating in a research note published on Monday morning, Marketbeat Ratings reports. The firm currently has $170.00 price objective on the stock, up from their prior price objective of $160.00. Several other equities research analysts also recently weighed […]
More Stories
Trump Says He May Wait to Announce VP at July GOP Convention
By Chase Smith As anticipation builds for who former President Donald Trump will choose as his 2024 running mate, the...
US Credit Card Debts Rise, More Americans Become Delinquent: NY Fed
By Naveen Athrappully Credit card debts and delinquency rates among Americans increased in the first quarter of 2024, with newly...
Gaza: World court opens hearings on request to halt Israel’s Rafah incursion
The International Court of Justice (ICJ) began public hearings on Thursday stemming from South Africa’s recent request for emergency provisional...
UN envoy outlines Iraq’s growth and ongoing struggles
Iraq is a nation brimming with potential but still haunted by legacies of past turmoil, the Special Representative of the...
World News in Brief: More Ukraine attacks, rights appeal for jailed Nigerian singer, International Day against Homophobia
The UN Humanitarian Coordinator for Ukraine condemned air strikes in Kherson city on Thursday, which injured dozens of civilians, including...
Special Counsel to Present Over 300 Exhibits in Hunter Biden Tax Evasion Trial
By Caden Pearson Special Counsel David Weiss is set to present over 300 exhibits, ranging from text messages to financial...